Gel treatment to help prevent scar tissue after pregnancy tissue removal
Part of Women’s health & pregnancy clinical trials.
This study tests whether an injected gel helps prevent scar tissue from forming again after a procedure to remove leftover pregnancy tissue inside the uterus. If you qualify, you may receive the gel as part of a randomized trial to see if it lowers the chance of re-adhesions (re-forming tissue sticking).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with retained products of conception (leftover pregnancy tissue).
- You can read and sign a consent form to join the study.
- You do not have severe complications from medications or surgery.
- You do not currently have genital tract inflammation (not an active or ongoing infection).
- You understand the study and are willing to be randomly assigned to a treatment group.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether managing a condition where pregnancy tissue remains in the womb (called retained products of conception) without immediate surgery is safe and effective. It might be an option for people who are stable and want to avoid more invasive procedures.
This trial tests if injecting vasopressin into the cervix reduces bleeding during surgery to remove leftover pregnancy tissue after a miscarriage, abortion, or childbirth. It may help make the procedure safer.
This study follows patients with retained products of conception (tissue left in the uterus after a pregnancy) to see how they are managed in real-world medical practice. You may join if an ultrasound shows a tissue area of at least half a centimeter.
This trial studies the best way to remove leftover pregnancy tissue after a first-trimester miscarriage. It compares approaches guided by a camera procedure in the uterus to see which helps most, especially for people who want to get pregnant again soon.
This trial tests if a treatment called platelet-rich plasma (a concentration of your own blood cells) can help prevent scar tissue from coming back after surgery for Asherman's syndrome, a condition where scar tissue forms inside the uterus.
This study tests a cross-linked hyaluronan gel placed in the uterus to help prevent painful or disruptive scar tissue (adhesions) after a procedure using ultrasound guidance. If you are eligible, the trial may help reduce the chance of future fertility and menstrual problems caused by scar tissue.
Hear when a new Retained Products of Conception trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.